Leggett & Platt (LEG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Q2 2024 sales were $1.129 billion, down 8% year-over-year, driven by weak residential demand, volume declines, and customer loss in Specialty Foam.
Reported EPS was $(4.39), reflecting a $675 million non-cash goodwill impairment, restructuring charges, and CEO transition costs; adjusted EPS was $0.29, down from $0.38 last year.
Restructuring plan is progressing ahead of schedule, with $73 million in debt paid down, $22 million in restructuring costs YTD, and sequential improvement in adjusted EBIT margin.
Strategic portfolio review underway to assess long-term fit and growth potential of each business.
Dividend reduced to $0.05 per share to prioritize debt reduction and financial strength.
Financial highlights
Q2 2024 EBIT was a loss of $614 million, driven by a $675 million goodwill impairment; adjusted EBIT was $71 million, down 23% year-over-year, with margin at 6.3%.
Q2 net loss attributable to shareholders was $(602.2) million; diluted EPS was $(4.39).
Operating cash flow for Q2 was $94 million, down $17 million year-over-year.
Adjusted EBITDA for the quarter was $103.8 million, margin 9.2%, down from 11.2% last year.
Net debt to trailing 12-month adjusted EBITDA was 3.83x at quarter end; total liquidity at June 30 was $705 million.
Outlook and guidance
2024 full-year sales expected at $4.3–$4.5 billion, down 5–9% from 2023, with adjusted EPS guidance narrowed to $1.10–$1.25.
Full-year reported EPS expected to be a loss of $3.43–$3.58, including $4.61 per share impact from goodwill impairment.
Adjusted EBIT margin expected at 6.5–6.9% for 2024; operating cash flow projected at $300–$350 million.
Restructuring plan expected to deliver $40–$50 million annualized EBIT benefit by late 2025, with $10–$15 million expected in 2024.
Capital expenditures projected at $110 million; dividends at $135 million.
Latest events from Leggett & Platt
- Shareholders are asked to approve a premium merger with Somnigroup, with Board support.LEG
Proxy filing9 Jul 2026 - 2024 saw lower sales and earnings, but restructuring improved margins and reduced debt.LEG
Q4 20249 Jul 2026 - Q1 2026 sales and earnings fell, guidance withdrawn, and merger and market risks increased.LEG
Q1 20267 May 2026 - 2025 sales declined but margins and debt improved; 2026 outlook targets efficiency and cash flow.LEG
Q4 202522 Apr 2026 - $2.5B all-stock acquisition expands global reach and targets $50M in annual synergies.LEG
M&A announcement14 Apr 2026 - Shareholders will vote virtually on directors, auditor, compensation, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at 2026 annual meeting.LEG
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026